Research Article - (2015) Volume 5, Issue 1
Initial Experience of Monitoring Response of Breast Cancer to Bevacizumab-containing Chemotherapy using A New Integrin Specific PET Imaging Tracer [F-18]RGD-K5
- Bahri S1,2*, Kain TS1, Mehta RS3, Herman J1, Kuzucan A2, Chen JH1,2, Kolb HC4, Walsh JC4 and Su MY1,2
- 1Department of Radiological Sciences, University of California, Irvine, CA, USA
- 2Tu and Yuen Center for Functional Onco-Imaging, University of California, Irvine, CA, USA
- 3Department of Medicine, University of California, Irvine, CA, USA
- 4Siemens MI, Biomarker Research, Culver City, CA, USA
*Corresponding Author:
Bahri S, Department of Radiological Sciences, 164 Irvine Hall, University of California, Irvine, CA 92697-5020, USA, Tel: (949) 824-6001
Email:
